SciELO - Brazil - Does mismatch negativity have utility for NMDA receptor drug development in depression? Does mismatch negativity have utility for NMDA receptor drug development in depression?

Por um escritor misterioso
Last updated 10 novembro 2024
SciELO - Brazil - Does mismatch negativity have utility for NMDA receptor  drug development in depression? Does mismatch negativity have utility for  NMDA receptor drug development in depression?
Rapid antidepressant effects associated with ketamine have shifted the landscape for the
SciELO - Brazil - Does mismatch negativity have utility for NMDA receptor  drug development in depression? Does mismatch negativity have utility for  NMDA receptor drug development in depression?
NMDA receptor trafficking in synaptic plasticity and
SciELO - Brazil - Does mismatch negativity have utility for NMDA receptor  drug development in depression? Does mismatch negativity have utility for  NMDA receptor drug development in depression?
PDF) Neuroprogression in schizophrenia: Pathways underpinning
SciELO - Brazil - Does mismatch negativity have utility for NMDA receptor  drug development in depression? Does mismatch negativity have utility for  NMDA receptor drug development in depression?
The Patient Experience of Recovery Following Anti-NMDA Receptor
SciELO - Brazil - Does mismatch negativity have utility for NMDA receptor  drug development in depression? Does mismatch negativity have utility for  NMDA receptor drug development in depression?
Selective Effects of the Loss of NMDA or mGluR5 Receptors in the
SciELO - Brazil - Does mismatch negativity have utility for NMDA receptor  drug development in depression? Does mismatch negativity have utility for  NMDA receptor drug development in depression?
PDF) Neuroprogression in schizophrenia: Pathways underpinning
SciELO - Brazil - Does mismatch negativity have utility for NMDA receptor  drug development in depression? Does mismatch negativity have utility for  NMDA receptor drug development in depression?
Frontiers Modulation of NMDA receptor activity by CR4056, an
SciELO - Brazil - Does mismatch negativity have utility for NMDA receptor  drug development in depression? Does mismatch negativity have utility for  NMDA receptor drug development in depression?
The NMDA receptor antagonist ketamine impairs and delays context
SciELO - Brazil - Does mismatch negativity have utility for NMDA receptor  drug development in depression? Does mismatch negativity have utility for  NMDA receptor drug development in depression?
N-Methyl D-aspartate receptor subunit signaling in fear extinction
SciELO - Brazil - Does mismatch negativity have utility for NMDA receptor  drug development in depression? Does mismatch negativity have utility for  NMDA receptor drug development in depression?
NMDARs in Cell Survival and Death: Implications in Stroke
SciELO - Brazil - Does mismatch negativity have utility for NMDA receptor  drug development in depression? Does mismatch negativity have utility for  NMDA receptor drug development in depression?
Signaling pathways responsible for the rapid antidepressant-like
SciELO - Brazil - Does mismatch negativity have utility for NMDA receptor  drug development in depression? Does mismatch negativity have utility for  NMDA receptor drug development in depression?
mGlu1 potentiation enhances prelimbic somatostatin interneuron
SciELO - Brazil - Does mismatch negativity have utility for NMDA receptor  drug development in depression? Does mismatch negativity have utility for  NMDA receptor drug development in depression?
Delivering medicines for depression and central nervous system
SciELO - Brazil - Does mismatch negativity have utility for NMDA receptor  drug development in depression? Does mismatch negativity have utility for  NMDA receptor drug development in depression?
Molecular mechanisms underlying the antidepressant actions of
SciELO - Brazil - Does mismatch negativity have utility for NMDA receptor  drug development in depression? Does mismatch negativity have utility for  NMDA receptor drug development in depression?
Teste 2nd by Second Digital - Issuu
SciELO - Brazil - Does mismatch negativity have utility for NMDA receptor  drug development in depression? Does mismatch negativity have utility for  NMDA receptor drug development in depression?
PDF) Neuroprogression in schizophrenia: Pathways underpinning

© 2014-2024 lexenimomnia.com. All rights reserved.